{
    "2018-10-15": [
        [
            {
                "time": "2018-10-12",
                "original_text": "乐普医疗：前三季净利11.43亿 同比增55%",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "净利",
                        "同比增",
                        "55%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-12",
                "original_text": "[看好评级]医药生物行业2018年三季报业绩前瞻：医药需求刚性 预计增长保持稳健",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "需求刚性",
                        "增长稳健"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-12",
                "original_text": "[推荐评级]医药行业周报：17种抗癌药纳入国家医保 研发驱动型企业长期受益",
                "features": {
                    "keywords": [
                        "抗癌药",
                        "国家医保",
                        "研发驱动",
                        "长期受益"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-12",
                "original_text": "【申万宏源医药闫天一团队】20181012周观点：医药需求刚性，预计增长保持稳健——医药生物行业2018年三季报业绩前瞻",
                "features": {
                    "keywords": [
                        "申万宏源",
                        "医药需求",
                        "增长稳健",
                        "三季报"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-12",
                "original_text": "医药行业周报：三季报临近 关注业绩确定性机会",
                "features": {
                    "keywords": [
                        "三季报",
                        "业绩确定性",
                        "机会"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-12",
                "original_text": "【数据揭秘】10月12日 融资客最看好的前20只个股",
                "features": {
                    "keywords": [
                        "融资客",
                        "看好",
                        "个股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-12",
                "original_text": "医药行业周报:估值吸引力强,期待三季报行情",
                "features": {
                    "keywords": [
                        "医药",
                        "估值吸引力",
                        "三季报"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}